Global Cord Blood Corporation reported earnings results for the fourth quarter ended March 31, 2022. For the fourth quarter, the company reported sales was CNY 297.21 million compared to CNY 302.32 million a year ago. Net income was CNY 104.72 million compared to CNY 127.73 million a year ago. Basic earnings per share from continuing operations was CNY 0.86 compared to CNY 1.05 a year ago. Diluted earnings per share from continuing operations was CNY 0.86 compared to CNY 1.05 a year ago.